Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Kidoguchi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Pharmacology|November 20, 2025
Simulation of perioperative Ibrutinib withdrawal using a population pharmacokinetic model and sparse clinical concentration dataSakiko Kimura, Ken-Ichi Sako, Nao Kikkawa, et al.
International Journal of Hematology|March 29, 2025
Histological confirmation and radiotherapy facilitate continuation of epcoritamab in a patient with tumor flare reactionMai Fujita, Sho Okamoto, Kazuki Jinnouchi, et al.
Internal Medicine (Tokyo, Japan)|March 20, 2020
Accelerated Phase of Atypical Chronic Myeloid Leukemia with Severe Disseminated Intravascular Coagulation at Initial PresentationMai Fujita, Kazuharu Kamachi, Masako Yokoo, et al.
The Tohoku Journal of Experimental Medicine|October 8, 2020
Concomitant Nephrotic Syndrome with Diffuse Large B-cell Lymphoma: A Case ReportKeisuke Kidoguchi, Hiroo Katsuya, Hiroshi Ureshino, et al.
Blood Neoplasia|October 15, 2025
Orally available decitabine prodrug OR-2100 induces mitotic perturbation for the treatment of double-hit lymphomaKeisuke Kidoguchi, Hiroshi Ureshino, Yuta Yamamoto, et al.
Annals of Hematology|September 29, 2018
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphomaHiroshi Ureshino, Kana Kusaba, Keisuke Kidoguchi, et al.
Blood Advances|January 8, 2024
Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cellsTatsuro Watanabe, Yuta Yamamoto, Yuki Kurahashi, et al.
The Tohoku Journal of Experimental Medicine|June 9, 2020
Successful Anti-TNF-Alpha Therapy for Crohn's Disease After Allogeneic Stem Cell Transplantation: A Case ReportKazuharu Kamachi, Toshihiko Ando, Nanae Tsuruoka, et al.
International Journal of Hematology|December 25, 2019
Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantationHiroshi Ureshino, Takero Shindo, Haruhiko Sano, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2019
Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) TranslocationsKazuharu Kamachi, Yasushi Kubota, Toshiaki Nagaie, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|November 20, 2025
Simulation of perioperative Ibrutinib withdrawal using a population pharmacokinetic model and sparse clinical concentration dataSakiko Kimura, Ken-Ichi Sako, Nao Kikkawa, et al.
International Journal of Hematology|March 29, 2025
Histological confirmation and radiotherapy facilitate continuation of epcoritamab in a patient with tumor flare reactionMai Fujita, Sho Okamoto, Kazuki Jinnouchi, et al.
Internal Medicine (Tokyo, Japan)|March 20, 2020
Accelerated Phase of Atypical Chronic Myeloid Leukemia with Severe Disseminated Intravascular Coagulation at Initial PresentationMai Fujita, Kazuharu Kamachi, Masako Yokoo, et al.
The Tohoku Journal of Experimental Medicine|October 8, 2020
Concomitant Nephrotic Syndrome with Diffuse Large B-cell Lymphoma: A Case ReportKeisuke Kidoguchi, Hiroo Katsuya, Hiroshi Ureshino, et al.
Blood Neoplasia|October 15, 2025
Orally available decitabine prodrug OR-2100 induces mitotic perturbation for the treatment of double-hit lymphomaKeisuke Kidoguchi, Hiroshi Ureshino, Yuta Yamamoto, et al.
Annals of Hematology|September 29, 2018
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphomaHiroshi Ureshino, Kana Kusaba, Keisuke Kidoguchi, et al.
Blood Advances|January 8, 2024
Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cellsTatsuro Watanabe, Yuta Yamamoto, Yuki Kurahashi, et al.
The Tohoku Journal of Experimental Medicine|June 9, 2020
Successful Anti-TNF-Alpha Therapy for Crohn's Disease After Allogeneic Stem Cell Transplantation: A Case ReportKazuharu Kamachi, Toshihiko Ando, Nanae Tsuruoka, et al.
International Journal of Hematology|December 25, 2019
Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantationHiroshi Ureshino, Takero Shindo, Haruhiko Sano, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2019
Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) TranslocationsKazuharu Kamachi, Yasushi Kubota, Toshiaki Nagaie, et al.
Pageof 3